347 related articles for article (PubMed ID: 10919590)
1. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.
van Besouw NM; van der Mast BJ; de Kuiper P; Smak Gregoor PJ; Vaessen LM; IJzermans JN; van Gelder T; Weimar W
Transplantation; 2000 Jul; 70(1):136-43. PubMed ID: 10919590
[TBL] [Abstract][Full Text] [Related]
2. Granzyme B ELISPOT assay determines the cytotoxic T lymphocyte precursor frequency after HLA-identical living-related kidney transplantation.
Gerrits JH; van de Wetering J; Ijzermans JN; Weimar W; van Besouw NM
Transplant Proc; 2005 Mar; 37(2):752-4. PubMed ID: 15848521
[TBL] [Abstract][Full Text] [Related]
3. Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression.
van der Mast BJ; van Besouw NM; de Kuiper P; Vaessen LM; Gregoor PJ; IJzermans JN; van Gelder T; Claas FH; Weimar W
Transplantation; 2001 Sep; 72(5):873-80. PubMed ID: 11571453
[TBL] [Abstract][Full Text] [Related]
4. Stable T-cell reactivity after successful tapering of azathioprine in HLA-identical living-related kidney transplant recipients despite minor histocompatibility antigen mismatches.
Gerrits JH; van de Wetering J; Postma S; Drabbels JJ; Vaessen LM; IJzermans JN; Rischen J; Claas FH; Weimar W; van Besouw NM
Nephrol Dial Transplant; 2007 Feb; 22(2):353-61. PubMed ID: 17124279
[TBL] [Abstract][Full Text] [Related]
5. Tapering immunosuppression in recipients of living donor kidney transplants.
Weimar W; Rischen-Vos J; de Kuiper P; Gregoor PJ; IJzermans JN; van Besouw NM; Baan CC; van der Mast BJ
Nephrol Dial Transplant; 2004 Jul; 19 Suppl 4():iv61-3. PubMed ID: 15240852
[TBL] [Abstract][Full Text] [Related]
6. A multiplex bead array analysis to monitor donor-specific cytokine responses after withdrawal of immunosuppression in HLA-identical living related kidney transplant patients.
Gerrits JH; van de Wetering J; van Beelen E; Claas FH; Weimar W; van Besouw NM
Transplant Proc; 2009 Jun; 41(5):1577-82. PubMed ID: 19545683
[TBL] [Abstract][Full Text] [Related]
7. Down-regulated donor-specific T-cell reactivity during successful tapering of immunosuppression after kidney transplantation.
van Besouw NM; van der Mast BJ; de Kuiper P; Smak regoor PJ; Vaessen LM; Ijzermans JN; van Gelder T; Weimar W
Clin Exp Immunol; 2002 May; 128(2):388-93. PubMed ID: 11985532
[TBL] [Abstract][Full Text] [Related]
8. Deficient TNF-alpha and IFN-gamma production correlates with nondetectable donor-specific cytotoxicity after clinical kidney transplantation.
van Besouw NM; de Kuiper R; van der Mast BJ; van de Wetering J; Baan CC; Weimar W
Transplantation; 2009 May; 87(10):1451-4. PubMed ID: 19461480
[TBL] [Abstract][Full Text] [Related]
9. After discontinuation of calcineurin inhibitors, tapering of mycophenolate mofetil further impairs donor-directed cytotoxicity.
van Besouw NM; van de Wetering J; van der Mast BJ; de Kuiper R; Baan CC; Weimar W
Clin Transplant; 2008; 22(2):129-35. PubMed ID: 18339130
[TBL] [Abstract][Full Text] [Related]
10. Persistence of donor-specific IL-2-secreting cells and cytotoxic T lymphocyte precursors in human kidney transplant recipients evidenced by limiting dilution analysis.
Lantz O; Alard P; Ben Aribia MH; Chavanel G; Fries D; Senik A; Charpentier B
J Immunol; 1990 May; 144(10):3748-55. PubMed ID: 2332630
[TBL] [Abstract][Full Text] [Related]
11. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin inhibitor withdrawal in stable kidney transplant patients decreases the donor-specific cytotoxic T lymphocyte precursor frequency.
van der Mast BJ; Rischen-Vos J; de Kuiper P; Vaessen LM; van Besouw NM; Weimar W
Transplantation; 2005 Nov; 80(9):1220-5. PubMed ID: 16314789
[TBL] [Abstract][Full Text] [Related]
14. Non-HLA T-cell reactivity during the first year after HLA-identical living-related kidney transplantation.
Gerrits JH; van de Wetering J; Drabbels JJ; IJzermans JN; Claas FH; Weimar W; van Besouw NM
Clin Transplant; 2009; 23(5):740-7. PubMed ID: 19563488
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of CD4+ CD25bright T cells in kidney transplant patients: improving suppression of donor-directed responses after transplantation.
Sewgobind VD; van der Laan LJ; Klepper M; Ijzermans JN; Tilanus HW; Weimar W; Baan CC
Clin Transplant; 2008; 22(5):579-86. PubMed ID: 18435785
[TBL] [Abstract][Full Text] [Related]
16. Allospecific CD154+ T cells identify rejection-prone recipients after pediatric small-bowel transplantation.
Ashokkumar C; Gupta A; Sun Q; Ningappa MB; Higgs BW; Mazariegos G; Fazzolare T; Remaley L; Soltys K; Bond G; Abu-Elmagd K; Sindhi R
Surgery; 2009 Aug; 146(2):166-73. PubMed ID: 19628070
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human heart-infiltrating cells after transplantation. V. Suppression of donor-specific allogeneic responses by cloned T-cell lines isolated from heart biopsy specimens of patients after transplantation.
Sell KW; Kanter K; Rodey GE; Wang YC; Ansari AA
J Heart Lung Transplant; 1992; 11(3 Pt 1):500-10. PubMed ID: 1351744
[TBL] [Abstract][Full Text] [Related]
18. CD4-veCD8-ve CD30+ve T cells are detectable in human lung transplant patients and their proportion of the lymphocyte population after in vitro stimulation with donor spleen cells correlates with preservation of lung physiology.
Polster K; Walker A; Fildes J; Entwistle G; Yonan N; Hutchinson IV; Leonard CT
Transplant Proc; 2005 Jun; 37(5):2257-60. PubMed ID: 15964393
[TBL] [Abstract][Full Text] [Related]
19. No predictive value of cytotoxic or helper T-cell precursor frequencies for outcome when analyzed from the graft after stem cell transplantation.
Kircher B; Niederwieser D; Gächter A; Lätzer K; Eibl G; Gastl G; Nachbaur D
Ann Hematol; 2004 Sep; 83(9):566-72. PubMed ID: 15170521
[TBL] [Abstract][Full Text] [Related]
20. Discontinuation of calcineurin inhibitors treatment allows the development of FOXP3+ regulatory T-cells in patients after kidney transplantation.
van de Wetering J; Koumoutsakos P; Peeters A; van der Mast BJ; de Kuiper P; IJzermans JN; Weimar W; Baan CC
Clin Transplant; 2011; 25(1):40-6. PubMed ID: 20636406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
